Cargando…

Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis

AIMS: Psoriatic arthritis (PsA) is associated with accelerated atherosclerosis due to underlying inflammation. Whether inflammatory burden and drugs used to suppress inflammation over time are associated with cardiovascular (CV) events remained unclear. This study aims to examine the time-varying ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Steven H., So, Ho, Cheng, Isaac T., Li, Edmund K., Wong, Priscilla, Li, Tena K., Lee, Alex Pui-Wai, Tam, Lai-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Extra-Articular Manifestations and Comorbidities in Spondyloarthritis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252335/ https://www.ncbi.nlm.nih.gov/pubmed/34262622 http://dx.doi.org/10.1177/1759720X211027712

Ejemplares similares

Psoriatic arthritis and the association with cardiometabolic disease: a narrative review
por: Karmacharya, Paras, et al.
Publicado: (2021)

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
por: Fragoulis, George E., et al.
Publicado: (2020)

Risk of community-acquired pneumonia requiring hospitalization in patients with spondyloarthritis
por: Chung, Ho Yin, et al.
Publicado: (2020)

Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

IBD considerations in spondyloarthritis
por: Di Jiang, Caroline, et al.
Publicado: (2020)

Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management
por: Parkinson, Joel T., et al.
Publicado: (2020)

Uveitis in spondyloarthritis
por: Rademacher, Judith, et al.
Publicado: (2020)

The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study
por: Redeker, Imke, et al.
Publicado: (2020)

Mast cells in spondyloarthritis, more than simple inflammatory bystanders?
por: Polivka, Laura, et al.
Publicado: (2020)

Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features?
por: Clunie, Gavin, et al.
Publicado: (2020)

Multidisciplinary working in the management of axial and peripheral spondyloarthritis
por: Gudu, Tania, et al.
Publicado: (2020)

Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis
por: Ladehesa-Pineda, María Lourdes, et al.
Publicado: (2020)

Skin manifestations in spondyloarthritis
por: Meier, Katharina, et al.
Publicado: (2020)

Increased risk of valvular heart disease in patients with ankylosing spondylitis: a nationwide population-based longitudinal cohort study
por: Siao, Wun-Zhih, et al.
Publicado: (2021)

Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system
por: How Shing Koy, Elsa, et al.
Publicado: (2021)

Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study
por: van der Horst-Bruinsma, Irene E., et al.
Publicado: (2021)

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
por: Michelena, Xabier, et al.
Publicado: (2022)

Autoinflammation in psoriatic arthritis: time to better define the multifaceted enemy
por: Bilgin, Emre
Publicado: (2022)

Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
por: Belasco, Jennifer, et al.
Publicado: (2015)

Caesarean section in women with axial spondyloarthritis and psoriatic arthritis: a population-based study
por: Götestam Skorpen, Carina, et al.
Publicado: (2023)

Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study
por: Proft, Fabian, et al.
Publicado: (2022)

Peripheral spondyloarthritis and psoriatic arthritis sine psoriase: are we dealing with semantics or clinically meaningful differences?
por: Ziade, Nelly, et al.
Publicado: (2022)

Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry
por: Ciurea, Adrian, et al.
Publicado: (2023)

Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
por: Maneiro, Jose Ramon, et al.
Publicado: (2015)

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials
por: McInnes, Iain B, et al.
Publicado: (2022)

Characterising axial psoriatic arthritis: correlation between whole spine MRI abnormalities and clinical, laboratory and radiographic findings
por: Diaz, Pamela, et al.
Publicado: (2022)

Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms
por: Frede, Natalie, et al.
Publicado: (2023)

Early Disease Activity or Clinical Response as Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
por: van der Heijde, D., et al.
Publicado: (2017)

Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
por: Menon, Bina, et al.
Publicado: (2014)

The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials
por: Denis, Agathe, et al.
Publicado: (2023)

Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study
por: Fernández‐Carballido, Cristina, et al.
Publicado: (2020)

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
por: López-Medina, Clementina, et al.
Publicado: (2021)

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study
por: López-Medina, Clementina, et al.
Publicado: (2021)

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
por: Schreiber, Stefan, et al.
Publicado: (2019)

Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up
por: Koehm, Michaela, et al.
Publicado: (2022)

Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies
por: Aureal, Melanie, et al.
Publicado: (2023)

Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M., et al.
Publicado: (2022)

Evolution of tricuspid regurgitation after transcatheter edge‐to‐edge mitral valve repair for secondary mitral regurgitation and its impact on mortality
por: Adamo, Marianna, et al.
Publicado: (2022)

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
por: Deodhar, Atul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d1m78loc5a5amro3sqajhlbnen